Myelodysplastic Syndromes in Dogs: Causes, Symptoms & Care

•25 March 2026

Myelodysplastic syndromes (MDS) in dogs are a group of disorders impacting their blood-forming stem cells, including red blood cells, white blood cells, and platelets. These syndromes cause abnormal maturation of haemopoietic stem cells and can be congenital or acquired due to underlying health issues. Understanding MDS is important for early detection and management of this challenging condition.

Recognising Symptoms of Myelodysplastic Syndromes in Dogs

Dogs affected by myelodysplastic syndromes often show clinical signs indicating serious health issues. Key symptoms to watch for include:

Weakness and lethargy
Pale gums and mucous membranes indicating anaemia
Unusual or excessive bleeding
Weight loss and poor body condition
Persistent or recurrent infections due to impaired immunity
Enlargement of the spleen and liver

Common Causes and Associated Conditions

MDS in dogs can arise from various causes, including:

Infections affecting bone marrow function
Bone marrow dysplasia leading to ineffective blood cell production
Immune-mediated neutropenia, sometimes linked to steroid treatments
Adverse reactions to medications or drugs, including estrogen or certain antibiotics

Additionally, MDS may be secondary to other serious health problems such as:

Lymphoma and leukemia
Myelofibrosis
Immune-mediated thrombocytopenia and haemolytic anaemia
Pyometra in female dogs given estrogen
Other blood disorders like polycythemia vera and thrombopathia

How Vets Diagnose Myelodysplastic Syndromes

Diagnosis requires thorough veterinary assessment, including detailed history and symptom development. To confirm MDS, vets typically recommend the following tests:

Complete blood count (CBC) to evaluate red and white blood cells and platelets
Biochemistry profile to assess organ function and metabolic status
Urinalysis
Bone marrow sampling to detect abnormal cell development

Treatment: Managing Underlying Causes and Providing Support

Treating MDS starts with identifying the root cause to guide therapy. Unfortunately, many dogs with MDS develop severe complications such as infections requiring intensive care. Hospitalisation is often necessary to monitor health closely.

Supportive treatments commonly include:

Blood transfusions to manage anaemia and bleeding risks
Antibiotic courses to control infections and stabilise white blood cell counts
Regular monitoring and adjustments to care based on response

Living with a Dog Diagnosed with Myelodysplastic Syndrome

After diagnosis and initial treatment, continuous veterinary follow-ups are essential to track progress. Despite early intervention, the prognosis for dogs with MDS remains guarded.

Providing a stable, low-stress environment and preventing exacerbation of symptoms is vital. Compassionate care focuses on maintaining quality of life, managing symptoms, and supporting the dog's health as much as possible.

Understanding Prognosis and Outcomes

Myelodysplastic syndromes in dogs present variable outcomes. Recent studies suggest survival times differ widely depending on MDS type and severity. While some cases respond to treatment such as erythropoietin for refractory anaemia, others have short survival times due to progressive bone marrow failure.

Risk factors influencing survival include body weight, blood cell levels, and degree of abnormal cells (blasts) in circulation. Accurate diagnosis and classification help guide prognosis and treatment planning.

Responsible Pet Ownership and Medical Care

If you suspect your dog is showing symptoms of MDS or any blood disorder, prompt veterinary evaluation is critical. Routine health checks and monitoring can help detect conditions early, improving chances for management.

Supporting your pet's health through regular vet visits, vaccinations, proper diet, and safe exposure to medications minimises risks of secondary health issues leading to complicated syndromes like MDS.

For those seeking puppies or new dogs, choosing reputable breeders and ensuring good genetic health screening is a responsible step to reduce congenital disease risk.